ZR-MTX for PIOL Phase II Trial

Clinical trial NCT06973811 · RECRUITING

Trial details

NCT number: NCT06973811
Sponsor: Peking Union Medical College Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Intraocular Lymphoma

Start date: 2025-05-21
Primary completion: 2027-10-30
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.